These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15819386)

  • 21. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
    Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry.
    Nowak M; Kołaczkowski M; Pawłowski M; Bojarski AJ
    J Med Chem; 2006 Jan; 49(1):205-14. PubMed ID: 16392805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
    J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
    Kossakowski J; Raszkiewicz A; Bugno R; Bojarski AJ
    Pol J Pharmacol; 2004; 56(6):843-8. PubMed ID: 15662099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S; Soskić V; Joksimović J
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
    Glennon RA; Ismaiel AE; McCarthy BG; Peroutka SJ
    Eur J Pharmacol; 1989 Sep; 168(3):387-92. PubMed ID: 2583244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
    Glennon RA; Naiman NA; Lyon RA; Titeler M
    J Med Chem; 1988 Oct; 31(10):1968-71. PubMed ID: 3172131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside.
    Ignjatović Đ; Vojnović Milutinović D; Nikolić-Kokić A; Slavić M; Andrić D; Tomić M; Kostić-Rajačić S
    Eur J Pharmacol; 2012 May; 683(1-3):93-100. PubMed ID: 22449382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors.
    Dutta AK; Fei XS; Reith ME
    Bioorg Med Chem Lett; 2002 Feb; 12(4):619-22. PubMed ID: 11844685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents.
    Zhang X; Hodgetts K; Rachwal S; Zhao H; Wasley JW; Craven K; Brodbeck R; Kieltyka A; Hoffman D; Bacolod MD; Girard B; Tran J; Thurkauf A
    J Med Chem; 2000 Oct; 43(21):3923-32. PubMed ID: 11052797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
    Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.